Abstract
Detection of large vessel occlusion (LVO) using machine learning on computed tomography angiography (CTA) may help stroke triage, yet applicability across varied patient and image characteristics has not been examined. The study will examine which characteristics are important when using a convolutional neural network to identify LVO on CTA. A retrospective cohort study (November 2017–May 2019) at a comprehensive stroke center evaluated 677 stroke-alerted patients with an LVO of the internal carotid artery, M1, or M2 (n=150) and a matching number without LVO were included. An Inception module-based network was trained for binary classification of LVO presence. Results were examined by LVO location, window settings, non-LVO findings, demographics, risk factors, presentation status and times, interventions, and outcomes. Three hundred patients were included (48% women; median age 65). Mean±95% CI for cross-validation test and external validation, respectively, are area under precision-recall curve 0.871±0.094 and 0.742±0.018 and area under receiver operating characteristic curve 0.920±0.051 and 0.852±0.004. 145 true positive (TP), 5 false negative (FN), 39 false positive (FP), and 111 true negative (TN) patients were identified. Significant comparisons (P<0.05) identified: lower window settings for misclassifications, smoking history for all FN versus 33% TP (P=0.005), and tissue plasminogen activator treatment for 41% FP versus 20% TN (P=0.017). Our LVO detection tool had high performance across patient characteristics with few exceptions. FP had pathology warranting detection, including distal occlusions. Lower window settings among misclassifications highlight the need for image quality when using machine learning for decision support.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the VICTR CTSA award (UTR000445 from NCATS/NIH), Vanderbilt University Medical Center institutional funding, and Patient-Centered Outcomes Research Institute (PCORI; contract CDRN-1306-04869). This work is partially supported by ViSE/VICTR VR3029 and by the National Science Foundation Graduate Research Fellowship under Grant No. DGE-1746891.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The institutional review board of Vanderbilt University gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
